Asian-American variants of human papillomavirus 16 and risk for cervical cancer:: a case-control study

被引:236
作者
Berumen, J
Ordoñez, RM
Lazcano, E
Salmeron, J
Galvan, SC
Estrada, RA
Yunes, E
Garcia-Carranca, A
Madrigal-de la Campa, A
机构
[1] Univ Ejercito & Fuerza Aerea, Lab Multidisciplinario Invest, Escuela Mil Grad Sanidad, Mexico City, DF, Mexico
[2] Univ Ejercito & Fuerza Aerea, Escuela Med Mil, Mexico City, DF, Mexico
[3] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico
[4] Ctr Med Nacl, Unidad Invest Epidemiol, Mexico City, DF, Mexico
[5] Ctr Med Nacl, Serv Salud, Mexico City, DF, Mexico
[6] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico
[7] Hosp Reg, Inst Mexicano Seguro SOcial, IMSS, Morelia, Michoacan, Mexico
[8] SSA Mexico, Inst Nacl Cancerol, Mexico City, DF, Mexico
[9] Hosp Gineco Obstet Castelazo Ayala, IMSS, Mexico City, DF, Mexico
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2001年 / 93卷 / 17期
关键词
D O I
10.1093/jnci/93.17.1325
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human papillomavirus 16 (HPV16) has a number of variants, each with a different geographic distribution and some that are associated more often with invasive neoplasias. We investigated whether the high incidence of cervical cancer in Mexico (50 cases per 100 000 women) may be associated with a high prevalence of oncogenic HPV16 variants. Methods: Cervical samples were collected from 181 case patients with cervical cancer and from 181 age-matched control subjects, all from Mexico City. HPV16 was detected with an E6/E7 gene-specific polymerase chain reaction, and variant HPV classes and subclasses were identified by sequencing regions of the E6 and L1/MY genes. Clinical data and data on tumor characteristics were also collected. All statistical tests were two-sided. Results: HPV16 was detected in cervical scrapes from 50.8% (92 of 181) of case patients and from 11% (20 of 181) of control subjects. All HPV16-positive samples, except one, contained European (E) or Asian-American (AA) variants. AA and E variants were found statistically significantly more often in case patients (AA = 23.2% [42 of 181]; E = 27.1% [49 of 181]) than in control subjects (AA = 1.1% [two of 181]; E = 10% [18 of 181]) (P < .001 for case versus control subjects for either E or AA variants, chi (2) test). However, the frequency of AA variants was 21 times higher in cancer patients than in control subjects, whereas that ratio for E variants was only 2.7 (P = .006, chi (2) test). The odds ratio (OR) for cervical cancer associated with AA variants (OR = 27.0; 95% confidence interval [CI] = 6.4 to 113.7) was higher than that associated with E variants (OR = 3.4; 95% CI = 1.9 to 6.0). AA-positive case patients (46.2 +/- 12.5 years [mean +/- standard deviation]) were 7.7 years younger than E-positive case patients (53.9 +/- 12.2 years) (P = .004, Student's t test). AA variants were associated with squamous cell carcinomas and adenocarcinomas, but E variants were associated with only squamous cell carcinomas (P = .014, Fisher's exact test). Conclusions: The high frequency of HPV16 AA variants, which appear to be more oncogenic than E variants, might contribute to the high incidence of cervical cancer in Mexico.
引用
收藏
页码:1325 / 1330
页数:6
相关论文
共 48 条
[1]   GENOME AMPLIFICATION OF HUMAN PAPILLOMAVIRUS TYPES 16 AND 18 IN CERVICAL CARCINOMAS IS RELATED TO THE RETENTION OF E1/E2 GENES [J].
BERUMEN, J ;
CASAS, L ;
SEGURA, E ;
AMEZCUA, JL ;
GARCIACARRANCA, A .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (05) :640-645
[2]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[3]  
Casas L, 1999, INT J CANCER, V83, P449, DOI 10.1002/(SICI)1097-0215(19991112)83:4&lt
[4]  
449::AID-IJC3&gt
[5]  
3.0.CO
[6]  
2-0
[7]   DECREASING INCIDENCE OF INVASIVE CERVICAL-CANCER IN YOUNG-WOMEN [J].
CHU, J ;
WHITE, E .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 157 (05) :1105-1107
[8]  
GALLUP DG, 1985, OBSTET GYNECOL, V65, P416
[9]   Evaluation of the cervical cancer screening programme in Mexico:: a population-based case-control study [J].
Hernández-Avila, M ;
Lazcano-Ponce, EC ;
de Ruíz, PA ;
Romieu, I .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1998, 27 (03) :370-376
[10]  
HernandezAvila M, 1997, ARCH MED RES, V28, P265